Patients like Kathy rely on genomic testing for life-saving care, so why are there still delays and inequities?
Kathy, like over 40% of newly diagnosed lung cancer patients, was diagnosed when her cancer was already Stage 4 and terminal. The good news? Genomic testing of Kathy’s cancer identified a specific gene for which there is a targeted treatment. Kathy takes a daily pill that is currently keeping her alive. “If every single lung […]